PACIFIC BIO CA
PACIFIC BIO CA operates in Diversified Metals & Mining.
PACIFIC BIO CA (P09) - Net Assets
Latest net assets as of June 2024: €492.70 Million EUR
Based on the latest financial reports, PACIFIC BIO CA (P09) has net assets worth €492.70 Million EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.51 Billion) and total liabilities (€1.02 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €492.70 Million |
| % of Total Assets | 32.64% |
| Annual Growth Rate | 35.27% |
| 5-Year Change | 1177.03% |
| 10-Year Change | N/A |
| Growth Volatility | 180.82 |
PACIFIC BIO CA - Net Assets Trend (2016–2023)
This chart illustrates how PACIFIC BIO CA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PACIFIC BIO CA (2016–2023)
The table below shows the annual net assets of PACIFIC BIO CA from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €701.30 Million | +24.59% |
| 2022-12-31 | €562.90 Million | -28.84% |
| 2021-12-31 | €790.99 Million | +135.77% |
| 2020-12-31 | €335.49 Million | +510.91% |
| 2019-12-31 | €54.92 Million | -51.85% |
| 2018-12-31 | €114.06 Million | +32.47% |
| 2017-12-31 | €86.10 Million | +1.69% |
| 2016-12-31 | €84.67 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PACIFIC BIO CA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 105153100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €2.54 Billion | 362.24% |
| Total Equity | €701.30 Million | 100.00% |
PACIFIC BIO CA Competitors by Market Cap
The table below lists competitors of PACIFIC BIO CA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SOLUTIANCE AG NA O.N.
F:SLSA
|
$14.47K |
|
Joby Aviation Inc.
NYSE:JOBY-WT
|
$14.48K |
|
Maua Capital Real Estate Fundo De Investimento Imobiliario
SA:MCRE11
|
$14.51K |
|
GOLDQUEST MINING
MU:M1W
|
$14.51K |
|
Monalisa Co. Ltd.
KQ:012690
|
$14.46K |
|
Console Labs S.A.
WAR:CLA
|
$14.46K |
|
Sonadezi Long Binh Share Holding Co
VN:SZB
|
$14.46K |
|
SEGMEN KARDESLER GIDA
IS:SEGMN
|
$14.40K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PACIFIC BIO CA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 562,904,000 to 701,304,000, a change of 138,400,000 (24.6%).
- Net loss of 306,735,000 reduced equity.
- New share issuances of 189,200,000 increased equity.
- Other factors increased equity by 255,935,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-306.74 Million | -43.74% |
| Share Issuances | €189.20 Million | +26.98% |
| Other Changes | €255.94 Million | +36.49% |
| Total Change | €- | 24.59% |
Book Value vs Market Value Analysis
This analysis compares PACIFIC BIO CA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.55x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.96x to 0.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.74 | €1.45 | x |
| 2018-12-31 | €0.76 | €1.45 | x |
| 2019-12-31 | €0.36 | €1.45 | x |
| 2020-12-31 | €1.74 | €1.45 | x |
| 2021-12-31 | €3.58 | €1.45 | x |
| 2022-12-31 | €2.49 | €1.45 | x |
| 2023-12-31 | €2.62 | €1.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PACIFIC BIO CA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -43.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -152.97%
- • Asset Turnover: 0.11x
- • Equity Multiplier: 2.49x
- Recent ROE (-43.74%) is above the historical average (-68.97%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -87.84% | -81.99% | 0.66x | 1.63x | €-82.84 Million |
| 2017 | -107.07% | -98.63% | 0.65x | 1.67x | €-100.80 Million |
| 2018 | -89.92% | -130.44% | 0.46x | 1.49x | €-113.97 Million |
| 2019 | -153.20% | -92.57% | 0.61x | 2.69x | €-89.63 Million |
| 2020 | 8.76% | 37.27% | 0.19x | 1.23x | €-4.15 Million |
| 2021 | -22.91% | -138.85% | 0.07x | 2.54x | €-260.32 Million |
| 2022 | -55.83% | -244.92% | 0.07x | 3.14x | €-370.54 Million |
| 2023 | -43.74% | -152.97% | 0.11x | 2.49x | €-376.87 Million |
Industry Comparison
This section compares PACIFIC BIO CA's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PACIFIC BIO CA (P09) | €492.70 Million | -87.84% | 2.06x | $14.46K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |